IC
KZIA

Ikarian Capital’s Kazia Therapeutics KZIA Stock Holding History

Ikarian Capital’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.58M Buy
+396,201
New +$4.83M 0.6% 49

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Ikarian Capital's KZIA Position: Q2 2026 in Review

Ikarian Capital opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 396,201 shares worth $5.58M. The stake represents 0.6% of the portfolio and ranks #49 among its holdings.

36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Ikarian Capital held 396,201 shares of Kazia Therapeutics worth $5.58M as of Q2 2026.
  • Kazia Therapeutics was a new Ikarian Capital position in Q2 2026.
  • Kazia Therapeutics made up 0.6% of Ikarian Capital's portfolio in Q2 2026, its #49 holding.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.